

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal absorption (GO:0050892) | 9.16596790 |
| 2 | angiotensin maturation (GO:0002003) | 6.72742723 |
| 3 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.28509678 |
| 4 | phospholipid efflux (GO:0033700) | 5.62406628 |
| 5 | desmosome organization (GO:0002934) | 5.56075607 |
| 6 | regulation of cholesterol esterification (GO:0010872) | 5.32629370 |
| 7 | regulation of triglyceride catabolic process (GO:0010896) | 5.21727367 |
| 8 | drug catabolic process (GO:0042737) | 5.12218400 |
| 9 | plasma lipoprotein particle assembly (GO:0034377) | 5.04440606 |
| 10 | NADH metabolic process (GO:0006734) | 5.03789099 |
| 11 | regulation of guanylate cyclase activity (GO:0031282) | 4.99839045 |
| 12 | regulation of bile acid biosynthetic process (GO:0070857) | 4.94224488 |
| 13 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.90531658 |
| 14 | flavonoid metabolic process (GO:0009812) | 4.87170605 |
| 15 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.83036344 |
| 16 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.83036344 |
| 17 | cobalamin metabolic process (GO:0009235) | 4.81845469 |
| 18 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.81798166 |
| 19 | cholesterol efflux (GO:0033344) | 4.76784994 |
| 20 | protein-lipid complex assembly (GO:0065005) | 4.76129668 |
| 21 | lipoprotein metabolic process (GO:0042157) | 4.75950908 |
| 22 | reverse cholesterol transport (GO:0043691) | 4.73829373 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 4.73806227 |
| 24 | negative regulation of cholesterol transport (GO:0032375) | 4.62039338 |
| 25 | negative regulation of sterol transport (GO:0032372) | 4.62039338 |
| 26 | cysteine metabolic process (GO:0006534) | 4.61555401 |
| 27 | homocysteine metabolic process (GO:0050667) | 4.50913074 |
| 28 | cholesterol homeostasis (GO:0042632) | 4.43876077 |
| 29 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.43732910 |
| 30 | vitamin A metabolic process (GO:0006776) | 4.43198603 |
| 31 | urea cycle (GO:0000050) | 4.41728411 |
| 32 | urea metabolic process (GO:0019627) | 4.41728411 |
| 33 | bile acid and bile salt transport (GO:0015721) | 4.40529233 |
| 34 | sterol homeostasis (GO:0055092) | 4.39367986 |
| 35 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.30666095 |
| 36 | plasma lipoprotein particle remodeling (GO:0034369) | 4.29170719 |
| 37 | protein-lipid complex remodeling (GO:0034368) | 4.29170719 |
| 38 | macromolecular complex remodeling (GO:0034367) | 4.29170719 |
| 39 | digestion (GO:0007586) | 4.28556701 |
| 40 | regulation of cholesterol homeostasis (GO:2000188) | 4.27469515 |
| 41 | sterol transport (GO:0015918) | 4.14427098 |
| 42 | cholesterol transport (GO:0030301) | 4.14427098 |
| 43 | establishment of skin barrier (GO:0061436) | 4.07296096 |
| 44 | L-phenylalanine catabolic process (GO:0006559) | 3.99625942 |
| 45 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.99625942 |
| 46 | nitrogen cycle metabolic process (GO:0071941) | 3.98585583 |
| 47 | fructose metabolic process (GO:0006000) | 3.97623550 |
| 48 | hormone catabolic process (GO:0042447) | 3.95522983 |
| 49 | digestive system process (GO:0022600) | 3.94948571 |
| 50 | regulation of water loss via skin (GO:0033561) | 3.92813789 |
| 51 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.92432451 |
| 52 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.92432451 |
| 53 | endocrine process (GO:0050886) | 3.92432451 |
| 54 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.91073922 |
| 55 | L-phenylalanine metabolic process (GO:0006558) | 3.91073922 |
| 56 | triglyceride homeostasis (GO:0070328) | 3.85753168 |
| 57 | acylglycerol homeostasis (GO:0055090) | 3.85753168 |
| 58 | keratinization (GO:0031424) | 3.81482678 |
| 59 | glycolipid catabolic process (GO:0019377) | 3.81155057 |
| 60 | adhesion of symbiont to host cell (GO:0044650) | 3.79269580 |
| 61 | virion attachment to host cell (GO:0019062) | 3.79269580 |
| 62 | transcytosis (GO:0045056) | 3.79051544 |
| 63 | multicellular organismal water homeostasis (GO:0050891) | 3.78972528 |
| 64 | sulfur amino acid catabolic process (GO:0000098) | 3.77649007 |
| 65 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.72078517 |
| 66 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.71460424 |
| 67 | phospholipid homeostasis (GO:0055091) | 3.67692628 |
| 68 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.66813908 |
| 69 | plasma lipoprotein particle organization (GO:0071827) | 3.66169731 |
| 70 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.65805298 |
| 71 | negative regulation of digestive system process (GO:0060457) | 3.61282244 |
| 72 | protein-lipid complex subunit organization (GO:0071825) | 3.58651823 |
| 73 | antimicrobial humoral response (GO:0019730) | 3.54074374 |
| 74 | renal system process involved in regulation of blood volume (GO:0001977) | 3.53801018 |
| 75 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.53284382 |
| 76 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.53284382 |
| 77 | regulation of systemic arterial blood pressure (GO:0003073) | 3.53238245 |
| 78 | plasma lipoprotein particle clearance (GO:0034381) | 3.52913739 |
| 79 | aromatic amino acid family catabolic process (GO:0009074) | 3.52758595 |
| 80 | modified amino acid transport (GO:0072337) | 3.49958853 |
| 81 | epoxygenase P450 pathway (GO:0019373) | 3.47672948 |
| 82 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.45217036 |
| 83 | ceramide catabolic process (GO:0046514) | 3.44590727 |
| 84 | lipoprotein transport (GO:0042953) | 3.44464290 |
| 85 | positive regulation of lipid catabolic process (GO:0050996) | 3.42888567 |
| 86 | glucose 6-phosphate metabolic process (GO:0051156) | 3.42845922 |
| 87 | antibacterial humoral response (GO:0019731) | 3.42689707 |
| 88 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.41276569 |
| 89 | adhesion of symbiont to host (GO:0044406) | 3.41053398 |
| 90 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.39497019 |
| 91 | lipid homeostasis (GO:0055088) | 3.38949493 |
| 92 | lysine catabolic process (GO:0006554) | 3.38552713 |
| 93 | lysine metabolic process (GO:0006553) | 3.38552713 |
| 94 | membrane lipid catabolic process (GO:0046466) | 3.36528813 |
| 95 | intestinal epithelial cell development (GO:0060576) | 3.36426125 |
| 96 | bile acid metabolic process (GO:0008206) | 3.35942602 |
| 97 | alpha-linolenic acid metabolic process (GO:0036109) | 3.35273636 |
| 98 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 3.35256351 |
| 99 | exogenous drug catabolic process (GO:0042738) | 3.33414144 |
| 100 | kynurenine metabolic process (GO:0070189) | 3.27775388 |
| 101 | cellular glucuronidation (GO:0052695) | 3.27122818 |
| 102 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.24114004 |
| 103 | drug metabolic process (GO:0017144) | 3.22405293 |
| 104 | ethanol oxidation (GO:0006069) | 3.20094126 |
| 105 | diacylglycerol metabolic process (GO:0046339) | 3.20060125 |
| 106 | cellular modified amino acid catabolic process (GO:0042219) | 3.20031010 |
| 107 | vitamin transmembrane transport (GO:0035461) | 3.19990700 |
| 108 | indole-containing compound catabolic process (GO:0042436) | 3.18485481 |
| 109 | indolalkylamine catabolic process (GO:0046218) | 3.18485481 |
| 110 | tryptophan catabolic process (GO:0006569) | 3.18485481 |
| 111 | regulation of phospholipase A2 activity (GO:0032429) | 3.18078342 |
| 112 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.18023855 |
| 113 | peptide catabolic process (GO:0043171) | 3.17959053 |
| 114 | drug transmembrane transport (GO:0006855) | 3.17256142 |
| 115 | fatty acid derivative transport (GO:1901571) | 3.16980521 |
| 116 | icosanoid transport (GO:0071715) | 3.16980521 |
| 117 | actin filament depolymerization (GO:0030042) | 3.16091394 |
| 118 | water homeostasis (GO:0030104) | 3.15125587 |
| 119 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.14371427 |
| 120 | amino-acid betaine metabolic process (GO:0006577) | 3.12078750 |
| 121 | positive regulation of pseudopodium assembly (GO:0031274) | 3.08784275 |
| 122 | drug transport (GO:0015893) | 3.07085079 |
| 123 | bile acid biosynthetic process (GO:0006699) | 3.05605182 |
| 124 | alkaloid metabolic process (GO:0009820) | 3.04322112 |
| 125 | glyoxylate metabolic process (GO:0046487) | 3.03362384 |
| 126 | tryptophan metabolic process (GO:0006568) | 3.01072002 |
| 127 | hemidesmosome assembly (GO:0031581) | 2.99216915 |
| 128 | sphingolipid catabolic process (GO:0030149) | 2.98341938 |
| 129 | arachidonic acid secretion (GO:0050482) | 2.97983490 |
| 130 | icosanoid secretion (GO:0032309) | 2.97983490 |
| 131 | heme transport (GO:0015886) | 2.97567046 |
| 132 | arginine metabolic process (GO:0006525) | 2.97172729 |
| 133 | regulation of sterol transport (GO:0032371) | 2.96236632 |
| 134 | regulation of cholesterol transport (GO:0032374) | 2.96236632 |
| 135 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.96217387 |
| 136 | regulation of cGMP biosynthetic process (GO:0030826) | 2.96212349 |
| 137 | regulation of cholesterol metabolic process (GO:0090181) | 2.96008084 |
| 138 | regulation of cellular extravasation (GO:0002691) | 2.95604160 |
| 139 | glucuronate metabolic process (GO:0019585) | 2.94314604 |
| 140 | uronic acid metabolic process (GO:0006063) | 2.94314604 |
| 141 | regulation of vitamin metabolic process (GO:0030656) | 2.93536867 |
| 142 | response to nitrosative stress (GO:0051409) | 2.92280859 |
| 143 | peptide hormone processing (GO:0016486) | 2.92267858 |
| 144 | proline metabolic process (GO:0006560) | 2.91966214 |
| 145 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.91897165 |
| 146 | glutamate metabolic process (GO:0006536) | 2.91189965 |
| 147 | ethanol metabolic process (GO:0006067) | 2.88607411 |
| 148 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.87835594 |
| 149 | regulation of keratinocyte differentiation (GO:0045616) | 2.83905570 |
| 150 | intestinal cholesterol absorption (GO:0030299) | 10.6021344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.34312244 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.42998147 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.29102110 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.99906260 |
| 5 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.60404216 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.57985473 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.94778843 |
| 8 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.69320960 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.17989935 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.15991124 |
| 11 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.92986333 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.91742620 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.75782548 |
| 14 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.64475865 |
| 15 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 2.54945067 |
| 16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.45542676 |
| 17 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 2.15170275 |
| 18 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.88108925 |
| 19 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.83169708 |
| 20 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.82853481 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.80897201 |
| 22 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.74504493 |
| 23 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.69676541 |
| 24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.69415455 |
| 25 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.67571387 |
| 26 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.60749719 |
| 27 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.59178593 |
| 28 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.51301661 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.39760424 |
| 30 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36827978 |
| 31 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.33986412 |
| 32 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.32466579 |
| 33 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.32254853 |
| 34 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29010167 |
| 35 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.28579131 |
| 36 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.26818581 |
| 37 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.26575305 |
| 38 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.26298970 |
| 39 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.26260380 |
| 40 | GATA1_22025678_ChIP-Seq_K562_Human | 1.26049366 |
| 41 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22466219 |
| 42 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.21475661 |
| 43 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.21115887 |
| 44 | ATF3_27146783_Chip-Seq_COLON_Human | 1.18352839 |
| 45 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.16585992 |
| 46 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.16141637 |
| 47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.16079374 |
| 48 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.16004037 |
| 49 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.15897240 |
| 50 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15119050 |
| 51 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.14929395 |
| 52 | GATA2_19941826_ChIP-Seq_K562_Human | 1.13176440 |
| 53 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13020044 |
| 54 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.12345233 |
| 55 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.11789748 |
| 56 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11471958 |
| 57 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.11451337 |
| 58 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.10684068 |
| 59 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.10429350 |
| 60 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.09977675 |
| 61 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.09565419 |
| 62 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09444011 |
| 63 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.07262377 |
| 64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.02506281 |
| 65 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.00740410 |
| 66 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.00289635 |
| 67 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.00027728 |
| 68 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.99030396 |
| 69 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.98467054 |
| 70 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98136296 |
| 71 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.96773181 |
| 72 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.96148559 |
| 73 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.95053031 |
| 74 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.94229939 |
| 75 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.93311360 |
| 76 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.92715002 |
| 77 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.92259596 |
| 78 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.92211977 |
| 79 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.91969904 |
| 80 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.91243425 |
| 81 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.91010281 |
| 82 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.90299163 |
| 83 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.89808086 |
| 84 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.89808086 |
| 85 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89425263 |
| 86 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.89218817 |
| 87 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.88173699 |
| 88 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.86768873 |
| 89 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.86438391 |
| 90 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.86034499 |
| 91 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.84072372 |
| 92 | P68_20966046_ChIP-Seq_HELA_Human | 0.83285812 |
| 93 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.82514169 |
| 94 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.81388636 |
| 95 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80938575 |
| 96 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.80240128 |
| 97 | GATA1_19941826_ChIP-Seq_K562_Human | 0.80156381 |
| 98 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.79839484 |
| 99 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.79233909 |
| 100 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.79164805 |
| 101 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.77627299 |
| 102 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.72563301 |
| 103 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.70669619 |
| 104 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.70427327 |
| 105 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.70077995 |
| 106 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.68473887 |
| 107 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.68400789 |
| 108 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.67493957 |
| 109 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.66770766 |
| 110 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.65819030 |
| 111 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.65189188 |
| 112 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.65164106 |
| 113 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.64317065 |
| 114 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.64156665 |
| 115 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.63635490 |
| 116 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.63493801 |
| 117 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.63219678 |
| 118 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.62400049 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 8.60399065 |
| 2 | MP0001666_abnormal_nutrient_absorption | 5.79309070 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 5.50107109 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.07284825 |
| 5 | MP0005365_abnormal_bile_salt | 4.50005888 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.73567226 |
| 7 | MP0003252_abnormal_bile_duct | 3.57781346 |
| 8 | MP0009840_abnormal_foam_cell | 3.51049117 |
| 9 | MP0010234_abnormal_vibrissa_follicle | 3.46754224 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.08361379 |
| 11 | MP0004264_abnormal_extraembryonic_tissu | 2.83704683 |
| 12 | MP0003705_abnormal_hypodermis_morpholog | 2.34918872 |
| 13 | MP0005083_abnormal_biliary_tract | 2.30908971 |
| 14 | MP0005409_darkened_coat_color | 2.27405894 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.19935013 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.11551170 |
| 17 | MP0000566_synostosis | 2.06191304 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.02969726 |
| 19 | MP0005084_abnormal_gallbladder_morpholo | 2.01834669 |
| 20 | MP0002796_impaired_skin_barrier | 1.93334434 |
| 21 | MP0000462_abnormal_digestive_system | 1.90748472 |
| 22 | MP0003183_abnormal_peptide_metabolism | 1.88195232 |
| 23 | MP0005332_abnormal_amino_acid | 1.86315171 |
| 24 | MP0003868_abnormal_feces_composition | 1.84420536 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 1.59420672 |
| 26 | MP0002254_reproductive_system_inflammat | 1.57109163 |
| 27 | MP0000609_abnormal_liver_physiology | 1.54315697 |
| 28 | MP0003866_abnormal_defecation | 1.44664268 |
| 29 | MP0000537_abnormal_urethra_morphology | 1.35707686 |
| 30 | MP0004782_abnormal_surfactant_physiolog | 1.29540759 |
| 31 | MP0005451_abnormal_body_composition | 1.26197680 |
| 32 | MP0001664_abnormal_digestion | 1.24849326 |
| 33 | MP0009643_abnormal_urine_homeostasis | 1.24798094 |
| 34 | MP0000678_abnormal_parathyroid_gland | 1.20371341 |
| 35 | MP0000538_abnormal_urinary_bladder | 1.17892407 |
| 36 | MP0005501_abnormal_skin_physiology | 1.17133572 |
| 37 | MP0010678_abnormal_skin_adnexa | 1.16818680 |
| 38 | MP0005448_abnormal_energy_balance | 1.16794316 |
| 39 | MP0005319_abnormal_enzyme/_coenzyme | 1.15679713 |
| 40 | MP0005670_abnormal_white_adipose | 1.13413036 |
| 41 | MP0004147_increased_porphyrin_level | 1.11627189 |
| 42 | MP0005381_digestive/alimentary_phenotyp | 1.11385413 |
| 43 | MP0010352_gastrointestinal_tract_polyps | 1.09206204 |
| 44 | MP0001663_abnormal_digestive_system | 1.08531733 |
| 45 | MP0000579_abnormal_nail_morphology | 1.07512694 |
| 46 | MP0001873_stomach_inflammation | 1.07234387 |
| 47 | MP0001188_hyperpigmentation | 1.07104511 |
| 48 | MP0003283_abnormal_digestive_organ | 1.05183410 |
| 49 | MP0002138_abnormal_hepatobiliary_system | 1.04964546 |
| 50 | MP0002822_catalepsy | 1.04520411 |
| 51 | MP0009697_abnormal_copulation | 1.01105701 |
| 52 | MP0010155_abnormal_intestine_physiology | 1.00943518 |
| 53 | MP0003300_gastrointestinal_ulcer | 1.00882156 |
| 54 | MP0004947_skin_inflammation | 1.00260338 |
| 55 | MP0009379_abnormal_foot_pigmentation | 1.00188739 |
| 56 | MP0003879_abnormal_hair_cell | 0.97366827 |
| 57 | MP0005220_abnormal_exocrine_pancreas | 0.96758611 |
| 58 | MP0002098_abnormal_vibrissa_morphology | 0.96312003 |
| 59 | MP0000477_abnormal_intestine_morphology | 0.96055990 |
| 60 | MP0009384_cardiac_valve_regurgitation | 0.95267437 |
| 61 | MP0003453_abnormal_keratinocyte_physiol | 0.94481318 |
| 62 | MP0001764_abnormal_homeostasis | 0.92312748 |
| 63 | MP0009053_abnormal_anal_canal | 0.90987409 |
| 64 | MP0006054_spinal_hemorrhage | 0.90449117 |
| 65 | MP0004043_abnormal_pH_regulation | 0.88382258 |
| 66 | MP0000467_abnormal_esophagus_morphology | 0.87836957 |
| 67 | MP0001216_abnormal_epidermal_layer | 0.86930992 |
| 68 | MP0002876_abnormal_thyroid_physiology | 0.86483641 |
| 69 | MP0002060_abnormal_skin_morphology | 0.84727175 |
| 70 | MP0004858_abnormal_nervous_system | 0.84241172 |
| 71 | MP0001849_ear_inflammation | 0.82729386 |
| 72 | MP0005636_abnormal_mineral_homeostasis | 0.78819136 |
| 73 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.78619171 |
| 74 | MP0001756_abnormal_urination | 0.76626610 |
| 75 | MP0003941_abnormal_skin_development | 0.76552623 |
| 76 | MP0003878_abnormal_ear_physiology | 0.75214347 |
| 77 | MP0005377_hearing/vestibular/ear_phenot | 0.75214347 |
| 78 | MP0009780_abnormal_chondrocyte_physiolo | 0.73561435 |
| 79 | MP0000427_abnormal_hair_cycle | 0.73117601 |
| 80 | MP0000598_abnormal_liver_morphology | 0.69661795 |
| 81 | MP0005666_abnormal_adipose_tissue | 0.68748463 |
| 82 | MP0000377_abnormal_hair_follicle | 0.68258023 |
| 83 | MP0000604_amyloidosis | 0.68074111 |
| 84 | MP0008004_abnormal_stomach_pH | 0.66896318 |
| 85 | MP0000490_abnormal_crypts_of | 0.66243792 |
| 86 | MP0002166_altered_tumor_susceptibility | 0.65028506 |
| 87 | MP0009642_abnormal_blood_homeostasis | 0.64250660 |
| 88 | MP0003638_abnormal_response/metabolism_ | 0.63204603 |
| 89 | MP0003195_calcinosis | 0.62457006 |
| 90 | MP0005167_abnormal_blood-brain_barrier | 0.62084820 |
| 91 | MP0003566_abnormal_cell_adhesion | 0.61724869 |
| 92 | MP0005257_abnormal_intraocular_pressure | 0.60843630 |
| 93 | MP0002136_abnormal_kidney_physiology | 0.60481787 |
| 94 | MP0000465_gastrointestinal_hemorrhage | 0.60052020 |
| 95 | MP0002089_abnormal_postnatal_growth/wei | 0.59971426 |
| 96 | MP0001765_abnormal_ion_homeostasis | 0.59819356 |
| 97 | MP0000383_abnormal_hair_follicle | 0.59378869 |
| 98 | MP0009765_abnormal_xenobiotic_induced | 0.58372328 |
| 99 | MP0009115_abnormal_fat_cell | 0.58241116 |
| 100 | MP0010771_integument_phenotype | 0.57110573 |
| 101 | MP0008872_abnormal_physiological_respon | 0.55152813 |
| 102 | MP0005166_decreased_susceptibility_to | 0.55123327 |
| 103 | MP0009764_decreased_sensitivity_to | 0.53672315 |
| 104 | MP0005266_abnormal_metabolism | 0.52827610 |
| 105 | MP0000367_abnormal_coat/_hair | 0.52650002 |
| 106 | MP0005408_hypopigmentation | 0.52081259 |
| 107 | MP0001845_abnormal_inflammatory_respons | 0.52035493 |
| 108 | MP0003329_amyloid_beta_deposits | 0.51193920 |
| 109 | MP0002896_abnormal_bone_mineralization | 0.50787301 |
| 110 | MP0005058_abnormal_lysosome_morphology | 0.50703547 |
| 111 | MP0002078_abnormal_glucose_homeostasis | 0.49893803 |
| 112 | MP0003656_abnormal_erythrocyte_physiolo | 0.49591452 |
| 113 | MP0000858_altered_metastatic_potential | 0.49468049 |
| 114 | MP0003959_abnormal_lean_body | 0.49286859 |
| 115 | MP0001191_abnormal_skin_condition | 0.49012926 |
| 116 | MP0005275_abnormal_skin_tensile | 0.48579719 |
| 117 | MP0008469_abnormal_protein_level | 0.48440598 |
| 118 | MP0003953_abnormal_hormone_level | 0.48352990 |
| 119 | MP0000762_abnormal_tongue_morphology | 0.48317921 |
| 120 | MP0005376_homeostasis/metabolism_phenot | 0.48183527 |
| 121 | MP0005076_abnormal_cell_differentiation | 0.47970867 |
| 122 | MP0003718_maternal_effect | 0.47644985 |
| 123 | MP0000249_abnormal_blood_vessel | 0.47060180 |
| 124 | MP0005248_abnormal_Harderian_gland | 0.46912674 |
| 125 | MP0005023_abnormal_wound_healing | 0.46616415 |
| 126 | MP0009931_abnormal_skin_appearance | 0.46333024 |
| 127 | MP0004185_abnormal_adipocyte_glucose | 0.44295624 |
| 128 | MP0002971_abnormal_brown_adipose | 0.43816968 |
| 129 | MP0000470_abnormal_stomach_morphology | 0.43095507 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypobetalipoproteinemia (HP:0003563) | 7.18730451 |
| 2 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 6.36985153 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 5.46920148 |
| 4 | Fat malabsorption (HP:0002630) | 5.41455383 |
| 5 | Acanthocytosis (HP:0001927) | 5.40515833 |
| 6 | Ileus (HP:0002595) | 5.38874634 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.21316823 |
| 8 | Xanthomatosis (HP:0000991) | 5.04928240 |
| 9 | Conjugated hyperbilirubinemia (HP:0002908) | 5.02448755 |
| 10 | Right ventricular cardiomyopathy (HP:0011663) | 4.82769552 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.80768738 |
| 12 | Malnutrition (HP:0004395) | 4.76871056 |
| 13 | Abnormality of proline metabolism (HP:0010907) | 4.23380032 |
| 14 | Hydroxyprolinuria (HP:0003080) | 4.23380032 |
| 15 | Systemic lupus erythematosus (HP:0002725) | 4.06918526 |
| 16 | Deep venous thrombosis (HP:0002625) | 4.06526398 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.05885785 |
| 18 | Hyperglycinuria (HP:0003108) | 4.00499041 |
| 19 | Epidermoid cyst (HP:0200040) | 3.93894666 |
| 20 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.81808156 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.73428370 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.61204060 |
| 23 | Hyperactive renin-angiotensin system (HP:0000841) | 3.55360086 |
| 24 | Hypercholesterolemia (HP:0003124) | 3.51932603 |
| 25 | Hemorrhage of the eye (HP:0011885) | 3.51799528 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.35906172 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.35906172 |
| 28 | Poikilocytosis (HP:0004447) | 3.33573184 |
| 29 | Hyperammonemia (HP:0001987) | 3.27172160 |
| 30 | Palmoplantar hyperkeratosis (HP:0000972) | 3.19966175 |
| 31 | Autoimmune thrombocytopenia (HP:0001973) | 3.18457181 |
| 32 | Pigmentary retinal degeneration (HP:0001146) | 3.13991104 |
| 33 | Steatorrhea (HP:0002570) | 3.10517536 |
| 34 | Prolonged partial thromboplastin time (HP:0003645) | 3.08593907 |
| 35 | Abdominal distention (HP:0003270) | 3.06052294 |
| 36 | Abnormality of nail color (HP:0100643) | 3.00870509 |
| 37 | Abnormality of purine metabolism (HP:0004352) | 2.99404896 |
| 38 | Hypoalphalipoproteinemia (HP:0003233) | 2.99218543 |
| 39 | Palmar hyperkeratosis (HP:0010765) | 2.94528589 |
| 40 | Abnormality of the common coagulation pathway (HP:0010990) | 2.90623474 |
| 41 | Decreased circulating renin level (HP:0003351) | 2.88947222 |
| 42 | Glomerulonephritis (HP:0000099) | 2.82326339 |
| 43 | Abnormality of nucleobase metabolism (HP:0010932) | 2.76814696 |
| 44 | Hypoglycemic coma (HP:0001325) | 2.75562318 |
| 45 | Complement deficiency (HP:0004431) | 2.68713649 |
| 46 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.68572168 |
| 47 | Abnormal hair laboratory examination (HP:0003328) | 2.68305277 |
| 48 | Hyperbilirubinemia (HP:0002904) | 2.60786669 |
| 49 | Cupped ribs (HP:0000887) | 2.59943484 |
| 50 | Thin bony cortex (HP:0002753) | 2.58732551 |
| 51 | Milia (HP:0001056) | 2.57107350 |
| 52 | Hyperlipoproteinemia (HP:0010980) | 2.56557374 |
| 53 | Wide cranial sutures (HP:0010537) | 2.54789917 |
| 54 | Esophageal varix (HP:0002040) | 2.53335824 |
| 55 | Ketosis (HP:0001946) | 2.51716682 |
| 56 | Abnormality of the intrinsic pathway (HP:0010989) | 2.48195494 |
| 57 | Metabolic acidosis (HP:0001942) | 2.48125398 |
| 58 | Alkalosis (HP:0001948) | 2.48073281 |
| 59 | Dehydration (HP:0001944) | 2.46015652 |
| 60 | Cholecystitis (HP:0001082) | 2.45446900 |
| 61 | Abnormal gallbladder physiology (HP:0012438) | 2.45446900 |
| 62 | Vascular calcification (HP:0004934) | 2.45088701 |
| 63 | Widely patent fontanelles and sutures (HP:0004492) | 2.44938877 |
| 64 | Facial shape deformation (HP:0011334) | 2.43502067 |
| 65 | Potter facies (HP:0002009) | 2.43502067 |
| 66 | Alopecia of scalp (HP:0002293) | 2.43231337 |
| 67 | Abnormality of renin-angiotensin system (HP:0000847) | 2.42604788 |
| 68 | Abnormality of urine glucose concentration (HP:0011016) | 2.39456832 |
| 69 | Glycosuria (HP:0003076) | 2.39456832 |
| 70 | Abnormality of vitamin metabolism (HP:0100508) | 2.38233413 |
| 71 | Chronic diarrhea (HP:0002028) | 2.33084908 |
| 72 | Late onset (HP:0003584) | 2.32242752 |
| 73 | Pancreatitis (HP:0001733) | 2.32060711 |
| 74 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.31634297 |
| 75 | Villous atrophy (HP:0011473) | 2.31480851 |
| 76 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.31480851 |
| 77 | Reticulocytosis (HP:0001923) | 2.31298900 |
| 78 | Increased IgE level (HP:0003212) | 2.30545360 |
| 79 | Exocrine pancreatic insufficiency (HP:0001738) | 2.29610152 |
| 80 | Increased mean platelet volume (HP:0011877) | 2.29554667 |
| 81 | Metabolic alkalosis (HP:0200114) | 2.28854851 |
| 82 | Nephrolithiasis (HP:0000787) | 2.28695293 |
| 83 | Skin nodule (HP:0200036) | 2.27914736 |
| 84 | Increased purine levels (HP:0004368) | 2.26245211 |
| 85 | Hyperuricemia (HP:0002149) | 2.26245211 |
| 86 | Plantar hyperkeratosis (HP:0007556) | 2.25251826 |
| 87 | Onycholysis (HP:0001806) | 2.22365905 |
| 88 | Nephritis (HP:0000123) | 2.21750401 |
| 89 | Autoimmune hemolytic anemia (HP:0001890) | 2.21592763 |
| 90 | Woolly hair (HP:0002224) | 2.21537556 |
| 91 | Ketoacidosis (HP:0001993) | 2.20750697 |
| 92 | Proximal tubulopathy (HP:0000114) | 2.20108766 |
| 93 | Hypotension (HP:0002615) | 2.19487896 |
| 94 | Hyperglycinemia (HP:0002154) | 2.19299318 |
| 95 | Cardiovascular calcification (HP:0011915) | 2.19043633 |
| 96 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.18610561 |
| 97 | Eczematoid dermatitis (HP:0000976) | 2.18088909 |
| 98 | Hypophosphatemia (HP:0002148) | 2.17436800 |
| 99 | Gout (HP:0001997) | 2.16794188 |
| 100 | Flat acetabular roof (HP:0003180) | 2.13282874 |
| 101 | Amyloidosis (HP:0011034) | 2.11546388 |
| 102 | Abnormal blistering of the skin (HP:0008066) | 2.11469835 |
| 103 | Gastrointestinal dysmotility (HP:0002579) | 2.09809265 |
| 104 | Hypotrichosis (HP:0001006) | 2.09188969 |
| 105 | Abnormality of carpal bone ossification (HP:0006257) | 2.08493858 |
| 106 | Fragile nails (HP:0001808) | 2.08471041 |
| 107 | Hepatocellular carcinoma (HP:0001402) | 2.06195740 |
| 108 | Confusion (HP:0001289) | 2.05524871 |
| 109 | Abnormal tarsal ossification (HP:0008369) | 2.05466962 |
| 110 | Myocardial infarction (HP:0001658) | 2.05234939 |
| 111 | Glomerulosclerosis (HP:0000096) | 2.04552317 |
| 112 | Congenital sensorineural hearing impairment (HP:0008527) | 2.03445841 |
| 113 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.98716406 |
| 114 | Atrophic scars (HP:0001075) | 1.98145453 |
| 115 | Hyperparathyroidism (HP:0000843) | 1.98132618 |
| 116 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.98103074 |
| 117 | Abnormality of complement system (HP:0005339) | 1.97248737 |
| 118 | Cholelithiasis (HP:0001081) | 1.96160869 |
| 119 | Axonal loss (HP:0003447) | 1.96088273 |
| 120 | Focal segmental glomerulosclerosis (HP:0000097) | 1.95879812 |
| 121 | Abnormality of methionine metabolism (HP:0010901) | 1.93937434 |
| 122 | Abnormal gallbladder morphology (HP:0012437) | 1.93536345 |
| 123 | Pili torti (HP:0003777) | 1.93378349 |
| 124 | Micronodular cirrhosis (HP:0001413) | 1.93165930 |
| 125 | Abnormal platelet volume (HP:0011876) | 1.92441012 |
| 126 | Abnormality of vitamin B metabolism (HP:0004340) | 1.92393962 |
| 127 | Abnormality of chloride homeostasis (HP:0011422) | 1.92087706 |
| 128 | Nausea (HP:0002018) | 1.91694416 |
| 129 | Pustule (HP:0200039) | 1.91526144 |
| 130 | Erythema (HP:0010783) | 1.91476416 |
| 131 | Thick nail (HP:0001805) | 1.89933407 |
| 132 | Subcapsular cataract (HP:0000523) | 1.89713208 |
| 133 | Rickets (HP:0002748) | 1.87746484 |
| 134 | Abnormality of the gastric mucosa (HP:0004295) | 1.87490625 |
| 135 | Megaloblastic anemia (HP:0001889) | 1.87413582 |
| 136 | Symptomatic seizures (HP:0011145) | 1.85933995 |
| 137 | Mesangial abnormality (HP:0001966) | 1.84752846 |
| 138 | Hypoglycemic seizures (HP:0002173) | 1.84138668 |
| 139 | Abnormality of the costochondral junction (HP:0000919) | 1.83637417 |
| 140 | Neonatal death (HP:0003811) | 1.83227772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.37887040 |
| 2 | MST1R | 4.66681966 |
| 3 | MST4 | 4.41811607 |
| 4 | EPHA2 | 4.06922805 |
| 5 | ACVR1B | 3.60078608 |
| 6 | ERN1 | 3.35490628 |
| 7 | MAP2K2 | 2.88839943 |
| 8 | LMTK2 | 2.74054736 |
| 9 | RIPK1 | 2.54524452 |
| 10 | PTK6 | 2.47836368 |
| 11 | GRK6 | 2.41424810 |
| 12 | LATS1 | 2.34954467 |
| 13 | MAP3K10 | 2.28836089 |
| 14 | BCKDK | 2.23101216 |
| 15 | PRKG2 | 2.22026728 |
| 16 | NME1 | 2.15861677 |
| 17 | STK39 | 2.06733739 |
| 18 | MET | 1.89034735 |
| 19 | MAP3K2 | 1.80513650 |
| 20 | AKT3 | 1.77303888 |
| 21 | TAOK3 | 1.77018942 |
| 22 | EPHB2 | 1.64412113 |
| 23 | FGFR3 | 1.58978431 |
| 24 | STK24 | 1.53796106 |
| 25 | PKN2 | 1.52954125 |
| 26 | ERBB4 | 1.47935380 |
| 27 | FGFR4 | 1.46928630 |
| 28 | NUAK1 | 1.41973811 |
| 29 | TRIB3 | 1.36799585 |
| 30 | FER | 1.35851522 |
| 31 | PTK2 | 1.35214395 |
| 32 | MAP3K7 | 1.28444012 |
| 33 | MAP2K1 | 1.26861471 |
| 34 | STK10 | 1.18662406 |
| 35 | PRPF4B | 1.18573431 |
| 36 | MAP3K3 | 1.14215032 |
| 37 | EPHB1 | 1.09441815 |
| 38 | MAPK11 | 1.08688365 |
| 39 | ERBB2 | 1.06046917 |
| 40 | SIK1 | 1.05130603 |
| 41 | MAP3K12 | 1.04177375 |
| 42 | INSRR | 1.01335730 |
| 43 | WNK4 | 0.99144832 |
| 44 | PRKAA2 | 0.96660362 |
| 45 | PRKCI | 0.96328502 |
| 46 | BMX | 0.95006909 |
| 47 | PIK3CA | 0.92089902 |
| 48 | TESK1 | 0.90102089 |
| 49 | TAOK1 | 0.89027445 |
| 50 | IRAK1 | 0.87167418 |
| 51 | MAP2K6 | 0.85093649 |
| 52 | DDR2 | 0.84350856 |
| 53 | MAP3K8 | 0.80367178 |
| 54 | CDC42BPA | 0.78400823 |
| 55 | IRAK3 | 0.78229830 |
| 56 | MAP3K11 | 0.77680337 |
| 57 | OXSR1 | 0.73550113 |
| 58 | KSR2 | 0.72753867 |
| 59 | LRRK2 | 0.72226647 |
| 60 | PAK4 | 0.70585161 |
| 61 | SMG1 | 0.70219457 |
| 62 | DYRK1B | 0.68658547 |
| 63 | ICK | 0.66826285 |
| 64 | TBK1 | 0.66686416 |
| 65 | MAP3K1 | 0.62775485 |
| 66 | MATK | 0.61467826 |
| 67 | STK3 | 0.60716520 |
| 68 | PDK2 | 0.58989775 |
| 69 | CDK6 | 0.58643223 |
| 70 | TYK2 | 0.57256868 |
| 71 | PAK3 | 0.55280282 |
| 72 | PAK2 | 0.54562540 |
| 73 | EPHA3 | 0.50523418 |
| 74 | IRAK2 | 0.49166118 |
| 75 | PDPK1 | 0.48888949 |
| 76 | EPHA4 | 0.48768883 |
| 77 | TESK2 | 0.48614015 |
| 78 | PDGFRA | 0.48530756 |
| 79 | PRKAA1 | 0.48314192 |
| 80 | MAP3K6 | 0.47142318 |
| 81 | RET | 0.47131646 |
| 82 | GRK1 | 0.46424139 |
| 83 | MYLK | 0.44789553 |
| 84 | NLK | 0.43448593 |
| 85 | STK38L | 0.41795592 |
| 86 | MAP2K4 | 0.41560586 |
| 87 | SCYL2 | 0.40268121 |
| 88 | CSK | 0.38764918 |
| 89 | FGFR1 | 0.38405256 |
| 90 | RPS6KB2 | 0.38285807 |
| 91 | GSK3A | 0.37349266 |
| 92 | CAMK2G | 0.37157875 |
| 93 | PIM2 | 0.34717413 |
| 94 | EEF2K | 0.34698439 |
| 95 | PRKCZ | 0.34322254 |
| 96 | FLT3 | 0.33298605 |
| 97 | JAK2 | 0.32679221 |
| 98 | PIK3CG | 0.32292223 |
| 99 | PRKACG | 0.31164534 |
| 100 | MAPKAPK2 | 0.30385354 |
| 101 | CDK12 | 0.29758278 |
| 102 | AKT2 | 0.29457275 |
| 103 | NEK9 | 0.27534704 |
| 104 | MAP4K1 | 0.27040147 |
| 105 | SGK494 | 0.26900982 |
| 106 | SGK223 | 0.26900982 |
| 107 | MAPKAPK3 | 0.26076734 |
| 108 | TAOK2 | 0.25393801 |
| 109 | MAP3K9 | 0.25172870 |
| 110 | MTOR | 0.24914982 |
| 111 | IRAK4 | 0.24629792 |
| 112 | ZAP70 | 0.24557462 |
| 113 | SRC | 0.24043402 |
| 114 | PDK1 | 0.23255909 |
| 115 | PRKCA | 0.23125115 |
| 116 | CAMK1D | 0.22468982 |
| 117 | FGR | 0.21490480 |
| 118 | PDGFRB | 0.21488024 |
| 119 | TTK | 0.20596345 |
| 120 | CSF1R | 0.20409809 |
| 121 | PBK | 0.20057952 |
| 122 | JAK1 | 0.19923997 |
| 123 | MAP2K3 | 0.19856334 |
| 124 | TGFBR2 | 0.19727568 |
| 125 | PRKCD | 0.18585328 |
| 126 | FYN | 0.18584708 |
| 127 | MELK | 0.18369290 |
| 128 | RPS6KA2 | 0.18176368 |
| 129 | IGF1R | 0.18155223 |
| 130 | CAMK2D | 0.18151875 |
| 131 | PRKD2 | 0.17203853 |
| 132 | CSNK1A1 | 0.16205046 |
| 133 | PRKCQ | 0.15855853 |
| 134 | ABL2 | 0.15014604 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.87953989 |
| 2 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.12548511 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.05867853 |
| 4 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.80340539 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.73306107 |
| 6 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.71110946 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.70599487 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.43321669 |
| 9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.35893841 |
| 10 | Mineral absorption_Homo sapiens_hsa04978 | 2.34854941 |
| 11 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.29118229 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.17186399 |
| 13 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.13125337 |
| 14 | Bile secretion_Homo sapiens_hsa04976 | 2.11285506 |
| 15 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.06558014 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 2.06422182 |
| 17 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.96024798 |
| 18 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.91004055 |
| 19 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.86342533 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.79142710 |
| 21 | Galactose metabolism_Homo sapiens_hsa00052 | 1.71965721 |
| 22 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.67976005 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.66616228 |
| 24 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.66268123 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.65748550 |
| 26 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.58039388 |
| 27 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.56087804 |
| 28 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.55638797 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.49985919 |
| 30 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.45170897 |
| 31 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.45153403 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.41140049 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.40651780 |
| 34 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.33714051 |
| 35 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.28561895 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.25081990 |
| 37 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.22806199 |
| 38 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.22546918 |
| 39 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.20692787 |
| 40 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.20270512 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.18741546 |
| 42 | Peroxisome_Homo sapiens_hsa04146 | 1.17434413 |
| 43 | Retinol metabolism_Homo sapiens_hsa00830 | 1.16442430 |
| 44 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.16131164 |
| 45 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.14303916 |
| 46 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.12702745 |
| 47 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.08968242 |
| 48 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.08170144 |
| 49 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.05511210 |
| 50 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.05345702 |
| 51 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.02401101 |
| 52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.01985203 |
| 53 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.00464219 |
| 54 | Carbon metabolism_Homo sapiens_hsa01200 | 0.94783955 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91977994 |
| 56 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.91667913 |
| 57 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.91378768 |
| 58 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.90800208 |
| 59 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.88896835 |
| 60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.88741974 |
| 61 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.77709110 |
| 62 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.74183619 |
| 63 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.70908754 |
| 64 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.67988179 |
| 65 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.65263711 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63670837 |
| 67 | Other glycan degradation_Homo sapiens_hsa00511 | 0.60031257 |
| 68 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.59743515 |
| 69 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.57483249 |
| 70 | Lysine degradation_Homo sapiens_hsa00310 | 0.56570092 |
| 71 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.54639441 |
| 72 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.48562574 |
| 73 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.48126413 |
| 74 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.47452518 |
| 75 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.46622555 |
| 76 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.44231521 |
| 77 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.43433835 |
| 78 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.41213046 |
| 79 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40947964 |
| 80 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34730539 |
| 81 | Tight junction_Homo sapiens_hsa04530 | 0.30615633 |
| 82 | Pertussis_Homo sapiens_hsa05133 | 0.24706226 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.23541275 |
| 84 | Bladder cancer_Homo sapiens_hsa05219 | 0.23382658 |
| 85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.22226958 |
| 86 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.22074913 |
| 87 | Sulfur relay system_Homo sapiens_hsa04122 | 0.20410458 |
| 88 | Adherens junction_Homo sapiens_hsa04520 | 0.16128863 |
| 89 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.15145905 |
| 90 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.14191891 |
| 91 | Hepatitis C_Homo sapiens_hsa05160 | 0.13884029 |
| 92 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.13534047 |
| 93 | Renin secretion_Homo sapiens_hsa04924 | 0.13309907 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.08538554 |
| 95 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.07225145 |
| 96 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.07090609 |
| 97 | Thyroid cancer_Homo sapiens_hsa05216 | 0.06797899 |
| 98 | Influenza A_Homo sapiens_hsa05164 | 0.06424613 |
| 99 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.05322356 |
| 100 | Circadian rhythm_Homo sapiens_hsa04710 | 0.04680268 |
| 101 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.04144736 |
| 102 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.03983531 |
| 103 | Asthma_Homo sapiens_hsa05310 | 0.03033476 |
| 104 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.03015658 |
| 105 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.01753630 |
| 106 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.01626033 |
| 107 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.01169027 |
| 108 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.00449088 |
| 109 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.0561376 |
| 110 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0250384 |
| 111 | Amoebiasis_Homo sapiens_hsa05146 | -0.0204439 |
| 112 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0158221 |
| 113 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | -0.0122717 |

